197 related articles for article (PubMed ID: 36913580)
1. In situ FRET-based localization of the N terminus of myosin binding protein-C in heart muscle cells.
Chandler J; Treacy C; Ameer-Beg S; Ehler E; Irving M; Kampourakis T
Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2222005120. PubMed ID: 36913580
[TBL] [Abstract][Full Text] [Related]
2. Site-specific phosphorylation of myosin binding protein-C coordinates thin and thick filament activation in cardiac muscle.
Ponnam S; Sevrieva I; Sun YB; Irving M; Kampourakis T
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15485-15494. PubMed ID: 31308242
[TBL] [Abstract][Full Text] [Related]
3. Nanosurfer assay dissects β-cardiac myosin and cardiac myosin-binding protein C interactions.
Touma AM; Tang W; Rasicci DV; Vang D; Rai A; Previs SB; Warshaw DM; Yengo CM; Sivaramakrishnan S
Biophys J; 2022 Jun; 121(12):2449-2460. PubMed ID: 35591788
[TBL] [Abstract][Full Text] [Related]
4. Myosin light chain phosphorylation enhances contraction of heart muscle via structural changes in both thick and thin filaments.
Kampourakis T; Sun YB; Irving M
Proc Natl Acad Sci U S A; 2016 May; 113(21):E3039-47. PubMed ID: 27162358
[TBL] [Abstract][Full Text] [Related]
5. Revealing the mechanism of how cardiac myosin-binding protein C N-terminal fragments sensitize thin filaments for myosin binding.
Inchingolo AV; Previs SB; Previs MJ; Warshaw DM; Kad NM
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):6828-6835. PubMed ID: 30877248
[TBL] [Abstract][Full Text] [Related]
6. RLC phosphorylation amplifies Ca2+ sensitivity of force in myocardium from cMyBP-C knockout mice.
Turner KL; Morris HS; Awinda PO; Fitzsimons DP; Tanner BCW
J Gen Physiol; 2023 Apr; 155(4):. PubMed ID: 36715675
[TBL] [Abstract][Full Text] [Related]
7. Cardiac myosin-binding protein C N-terminal interactions with myosin and actin filaments: Opposite effects of phosphorylation and M-domain mutations.
Wong FL; Bunch TA; Lepak VC; Steedman AL; Colson BA
J Mol Cell Cardiol; 2024 Jan; 186():125-137. PubMed ID: 38008210
[TBL] [Abstract][Full Text] [Related]
8. Omecamtiv mercabil and blebbistatin modulate cardiac contractility by perturbing the regulatory state of the myosin filament.
Kampourakis T; Zhang X; Sun YB; Irving M
J Physiol; 2018 Jan; 596(1):31-46. PubMed ID: 29052230
[TBL] [Abstract][Full Text] [Related]
9. Amino terminus of cardiac myosin binding protein-C regulates cardiac contractility.
Lynch TL; Kumar M; McNamara JW; Kuster DWD; Sivaguru M; Singh RR; Previs MJ; Lee KH; Kuffel G; Zilliox MJ; Lin BL; Ma W; Gibson AM; Blaxall BC; Nieman ML; Lorenz JN; Leichter DM; Leary OP; Janssen PML; de Tombe PP; Gilbert RJ; Craig R; Irving T; Warshaw DM; Sadayappan S
J Mol Cell Cardiol; 2021 Jul; 156():33-44. PubMed ID: 33781820
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy mutation R58Q in the myosin regulatory light chain perturbs thick filament-based regulation in cardiac muscle.
Kampourakis T; Ponnam S; Irving M
J Mol Cell Cardiol; 2018 Apr; 117():72-81. PubMed ID: 29452157
[TBL] [Abstract][Full Text] [Related]
11. Myosin-binding protein C displaces tropomyosin to activate cardiac thin filaments and governs their speed by an independent mechanism.
Mun JY; Previs MJ; Yu HY; Gulick J; Tobacman LS; Beck Previs S; Robbins J; Warshaw DM; Craig R
Proc Natl Acad Sci U S A; 2014 Feb; 111(6):2170-5. PubMed ID: 24477690
[TBL] [Abstract][Full Text] [Related]
12. The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position.
Mun JY; Kensler RW; Harris SP; Craig R
J Mol Cell Cardiol; 2016 Feb; 91():141-7. PubMed ID: 26718724
[TBL] [Abstract][Full Text] [Related]
13. Ablation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes.
McNamara JW; Li A; Smith NJ; Lal S; Graham RM; Kooiker KB; van Dijk SJ; Remedios CGD; Harris SP; Cooke R
J Mol Cell Cardiol; 2016 May; 94():65-71. PubMed ID: 27021517
[TBL] [Abstract][Full Text] [Related]
14. Human cardiac myosin-binding protein C phosphorylation- and mutation-dependent structural dynamics monitored by time-resolved FRET.
Kanassatega RS; Bunch TA; Lepak VC; Wang C; Colson BA
J Mol Cell Cardiol; 2022 May; 166():116-126. PubMed ID: 35227736
[TBL] [Abstract][Full Text] [Related]
15. Stress-dependent activation of myosin in the heart requires thin filament activation and thick filament mechanosensing.
Park-Holohan SJ; Brunello E; Kampourakis T; Rees M; Irving M; Fusi L
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33850019
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional effects of myosin-binding protein-C phosphorylation in heart muscle are not mimicked by serine-to-aspartate substitutions.
Kampourakis T; Ponnam S; Sun YB; Sevrieva I; Irving M
J Biol Chem; 2018 Sep; 293(37):14270-14275. PubMed ID: 30082313
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of cardiac myosin binding protein C releases myosin heads from the surface of cardiac thick filaments.
Kensler RW; Craig R; Moss RL
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):E1355-E1364. PubMed ID: 28167762
[TBL] [Abstract][Full Text] [Related]
18. Cardiac myosin-binding protein C interaction with actin is inhibited by compounds identified in a high-throughput fluorescence lifetime screen.
Bunch TA; Guhathakurta P; Lepak VC; Thompson AR; Kanassatega RS; Wilson A; Thomas DD; Colson BA
J Biol Chem; 2021 Jul; 297(1):100840. PubMed ID: 34052227
[TBL] [Abstract][Full Text] [Related]
19. Microscale thermophoresis suggests a new model of regulation of cardiac myosin function via interaction with cardiac myosin-binding protein C.
Ponnam S; Kampourakis T
J Biol Chem; 2022 Jan; 298(1):101485. PubMed ID: 34915024
[TBL] [Abstract][Full Text] [Related]
20. E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.
De Lange WJ; Grimes AC; Hegge LF; Spring AM; Brost TM; Ralphe JC
J Gen Physiol; 2013 Sep; 142(3):241-55. PubMed ID: 23980194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
